PATENT CLAIM ANALYSIS

Application Number: 15861750
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "307000"]

Abstract:
Derivatives of 1,2,3,4-tetrahydroisoquinoline (THIQ) having the general formula A-(CH 2 ) n —B are provided, wherein A is THIQ or a substituted derivative thereof and B is an aryl, cycloalkylaryl, or cycloalkyl group, wherein A and B are linked to each other by an alkyl or substituted alkyl chain. The compounds are useful as selective ligands (agonists or antagonists) of central nervous system receptors, and in particular of the seratonin receptors. The compounds or their salts can be formulated into pharmaceutical in need thereof by any route of administration suitable for a desired treatment protocol and especially for the treatment of psychiatric disorders.

Claim (Index 5):
The serotonin receptor ligand of  claim 1 , wherein the ligand is selected from the group consisting of: or a salt of any thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.56
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11757246', '11628132', '12301180', '12643175', '12018172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948496575748745
- 35 USC 102 Novelty (BERT): 0.5077642818084642
- Combined Prediction Score: 0.7661411199982334
- Mean Citation Score: 206.899168
- Max Citation Score: 208.25078
- Similarity Product: 116.44847155999302

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test